MESTASTOP SOLUTIONS PVT LTD

Startup

Mestastop Solutions is a cutting-edge biotechnology company dedicated to building therapies focused on delaying cancer metastasis. With a focus on patient data-driven innovation, Mestastop has developed three advanced platforms that now empower them to create IP around metastasis-focused drug discovery, drug repurposing and companion diagnostics.

At Mestastop, we leverage the power of wet lab biology, patient survival and metastasis correlation using machine learning algorithms to unlock valuable insights from complex biological datasets, enabling us to identify translationally relevant, critical rate-limiting steps for metastatic success. Our team of experts then combines deep domain knowledge with state-of-the-art technologies to identify, validate novel first-in-class targets, and subsequently develop novel programmes against cancer metastasis. 

Through our innovative approach of understanding and integrating metastasis biology from patient samples to data, Mestastop is at the forefront of driving transformative change in the way cancer will be treated and managed, by delaying metastasis (in a proliferation independent pathway) in an adjuvant setting for high-risk primary tumour patients, identified using their companion diagnostics. 

Mestastop currently have five products in its pipeline, with three novel discovery programmes in early discovery and two new methods of use applications, preparing for Ph2A clinical trials. 

Visit our booth at BioTechX Europe 2025 to learn more about how Mestastop Solutions is shaping the future of anti-cancer treatment.

website